Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021

This study determined the percentage of children and adult samples from the St. Louis metropolitan area in Missouri with SARS-CoV-2 antibodies during three collection periods spanning April 2020 to January 2021. By January 2021, 20.68% of the tested individuals had antibodies. These results show th...

Full description

Bibliographic Details
Main Authors:	Brittany K. Smith, Andrew B. Janowski, Arim C. Fremont, Lucas J. Adams, Ya-Nan Dai, Christopher W. Farnsworth, Ann M. Gronowski, Stephen M. Roper, David Wang, Daved H. Fremont
Format:	Article
Language:	English
Published:	American Society for Microbiology 2021-08-01
Series:	mSphere
Online Access:	https://journals.asm.org/doi/10.1128/mSphere.00450-21

id	doaj-03493d85b1f24ed48508e23aff4fec42
record_format	Article
spelling	doaj-03493d85b1f24ed48508e23aff4fec422021-09-21T19:41:35ZengAmerican Society for MicrobiologymSphere2379-50422021-08-016410.1128/mSphere.00450-21Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021Brittany K. Smith0Andrew B. Janowski1https://orcid.org/0000-0003-4382-1194Arim C. Fremont2Lucas J. Adams3Ya-Nan Dai4Christopher W. Farnsworth5https://orcid.org/0000-0001-7169-3850Ann M. Gronowski6Stephen M. Roper7David Wang8https://orcid.org/0000-0002-0827-196XDaved H. Fremont9https://orcid.org/0000-0002-8544-2689Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USADepartment of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USADepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USADepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USADepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USADepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USADepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USADepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USADepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USADepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USA This study determined the percentage of children and adult samples from the St. Louis metropolitan area in Missouri with SARS-CoV-2 antibodies during three collection periods spanning April 2020 to January 2021. By January 2021, 20.68% of the tested individuals had antibodies. These results show the evolution of the SARS-CoV-2 pandemic in St. Louis, Missouri, and provide a snapshot of the extent of infection just prior to the start of mass vaccination.https://journals.asm.org/doi/10.1128/mSphere.00450-21
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Brittany K. Smith Andrew B. Janowski Arim C. Fremont Lucas J. Adams Ya-Nan Dai Christopher W. Farnsworth Ann M. Gronowski Stephen M. Roper David Wang Daved H. Fremont
spellingShingle	Brittany K. Smith Andrew B. Janowski Arim C. Fremont Lucas J. Adams Ya-Nan Dai Christopher W. Farnsworth Ann M. Gronowski Stephen M. Roper David Wang Daved H. Fremont Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021 mSphere
author_facet	Brittany K. Smith Andrew B. Janowski Arim C. Fremont Lucas J. Adams Ya-Nan Dai Christopher W. Farnsworth Ann M. Gronowski Stephen M. Roper David Wang Daved H. Fremont
author_sort	Brittany K. Smith
title	Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021
title_short	Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021
title_full	Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021
title_fullStr	Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021
title_full_unstemmed	Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021
title_sort	progression of sars-cov-2 seroprevalence in st. louis, missouri, through january 2021
publisher	American Society for Microbiology
series	mSphere
issn	2379-5042
publishDate	2021-08-01
description	This study determined the percentage of children and adult samples from the St. Louis metropolitan area in Missouri with SARS-CoV-2 antibodies during three collection periods spanning April 2020 to January 2021. By January 2021, 20.68% of the tested individuals had antibodies. These results show the evolution of the SARS-CoV-2 pandemic in St. Louis, Missouri, and provide a snapshot of the extent of infection just prior to the start of mass vaccination.
url	https://journals.asm.org/doi/10.1128/mSphere.00450-21
work_keys_str_mv	AT brittanyksmith progressionofsarscov2seroprevalenceinstlouismissourithroughjanuary2021 AT andrewbjanowski progressionofsarscov2seroprevalenceinstlouismissourithroughjanuary2021 AT arimcfremont progressionofsarscov2seroprevalenceinstlouismissourithroughjanuary2021 AT lucasjadams progressionofsarscov2seroprevalenceinstlouismissourithroughjanuary2021 AT yanandai progressionofsarscov2seroprevalenceinstlouismissourithroughjanuary2021 AT christopherwfarnsworth progressionofsarscov2seroprevalenceinstlouismissourithroughjanuary2021 AT annmgronowski progressionofsarscov2seroprevalenceinstlouismissourithroughjanuary2021 AT stephenmroper progressionofsarscov2seroprevalenceinstlouismissourithroughjanuary2021 AT davidwang progressionofsarscov2seroprevalenceinstlouismissourithroughjanuary2021 AT davedhfremont progressionofsarscov2seroprevalenceinstlouismissourithroughjanuary2021
_version_	1717372150206169088

Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021

Similar Items